Abiopharma

New Form SCHEDULE 13G/A - CARGO Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0000315066-25-002179 Size: 10 KB

The latest from NRC Health | Can we embrace AI without losing humanity, the latest CAHPS Insider, and so much more!

New Form SCHEDULE 13G/A - 10x Genomics, Inc. Filed: 2025-08-07 AccNo: 0000315066-25-002176 Size: 14 KB

SeaStar Medical - SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

New Form SCHEDULE 13G/A - HARVARD BIOSCIENCE INC Filed: 2025-08-07 AccNo: 0001019432-25-000022 Size: 7 KB

New Form 10-Q - ELI LILLY & Co Filed: 2025-08-07 AccNo: 0000059478-25-000204 Size: 10 MB

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

New Form SCHEDULE 13G/A - Qualigen Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001213900-25-072867 Size: 6 KB

Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology

New Form 10-Q - AVADEL PHARMACEUTICALS PLC Filed: 2025-08-07 AccNo: 0001012477-25-000024 Size: 5 MB

New Form 4 - SENSIENT TECHNOLOGIES CORP Filed: 2025-08-07 AccNo: 0001127602-25-020206 Size: 4 KB

New Form 10-Q - DENTSPLY SIRONA Inc. Filed: 2025-08-07 AccNo: 0000818479-25-000155 Size: 11 MB

Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with Novel PDE4 Inhibitor, PALI-2108